Relevium Technologies Stock Forecast, Price & News

Wall Street analysts have given Relevium Technologies a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Relevium Technologies wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Relevium Technologies' stock was trading at C$0.02 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, RLV shares have increased by 33.3% and is now trading at C$0.02.
View which stocks have been most impacted by COVID-19.

Some companies that are related to Relevium Technologies include Vigil Health Solutions (VGL), Ambu A/S (AMBBY), Ansell (ANSLY), Ansell (ANSLF), Ansell (ANN), Austco Healthcare (AHC), BATM Advanced Communications (BTAVF), Carl Zeiss Meditec (CZMWY), CeCors (CEOS), Clover (CLV), Coloplast A/S (CLPBF), ConvaTec Group (CNVVY), Core One Labs (CLABF), Demant A/S (WILLF) and Essilor International Société Anonyme (EI).
View all of RLV's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Relevium Technologies investors own include Arctic Star Exploration (ADD), Eldorado Gold (ELD), Freedom Leaf (FRLF), Macquarie Infrastructure (MIC), Spero Therapeutics (SPRO), SoFi Weekly Income ETF (TGIF), Acquired Sales (AQSP), Aphria (APHA), (APHA) and Aldeyra Therapeutics (ALDX).

Relevium Technologies trades on the Canadian Venture Exchange (CVE) under the ticker symbol "RLV."

Shares of RLV and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

One share of RLV stock can currently be purchased for approximately C$0.02.

Relevium Technologies has a market capitalization of C$4.22 million and generates C$1.00 million in revenue each year.

The official website for Relevium Technologies is www.releviumcorp.com.

Relevium Technologies is headquartered at 1000 Sherbrooke St W Suite 2700, MONTREAL, QC H3A 3G4, Canada.

Relevium Technologies' mailing address is 1000 Sherbrooke St W Suite 2700, MONTREAL, QC H3A 3G4, Canada. The company can be reached via phone at +1-514-8248559.